BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37778636)

  • 21. Adenomyosis interferes with accurate ultrasonographic detection of uterine leiomyomas.
    Harmanli OH; Bevilacqua SA; Dandolu V; Chatwani AJ; Hernandez E
    Arch Gynecol Obstet; 2005 Dec; 273(3):146-9. PubMed ID: 16001190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
    Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.
    Kim H; Rha SE; Shin YR; Kim EH; Park SY; Lee SL; Lee A; Kim MR
    Korean J Radiol; 2024 Jan; 25(1):43-54. PubMed ID: 38184768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Huge uterine leiomyoma with degenerative changes mimicking ovarian carcinoma--a case report].
    Gajewska M; Kosińska-Kaczyńska K; Marczewska J; Kamiński P
    Ginekol Pol; 2013 Feb; 84(2):147-50. PubMed ID: 23668063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
    Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
    Takeuchi M; Matsuzaki K; Harada M
    Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
    Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.
    Yilmaz N; Sahin I; Kilic S; Ozgu E; Gungor T; Bilge U
    Eur J Gynaecol Oncol; 2009; 30(4):412-4. PubMed ID: 19761133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
    Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
    J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
    Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
    Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of contrast-enhanced ultrasound for the differential diagnosis of specific subtypes of uterine leiomyomas.
    Li Z; Zhang P; Shen H; Ding B; Wang H; Li J; Shen Y
    J Obstet Gynaecol Res; 2021 Jan; 47(1):311-319. PubMed ID: 33073436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases.
    Toyohara Y; Sone K; Noda K; Yoshida K; Kurokawa R; Tanishima T; Kato S; Inui S; Nakai Y; Ishida M; Gonoi W; Tanimoto S; Takahashi Y; Inoue F; Kukita A; Kawata Y; Taguchi A; Furusawa A; Miyamoto Y; Tsukazaki T; Tanikawa M; Iriyama T; Mori-Uchino M; Tsuruga T; Oda K; Yasugi T; Takechi K; Abe O; Osuga Y
    Sci Rep; 2022 Nov; 12(1):19612. PubMed ID: 36385486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of contrast-enhanced ultrasound in uterine leiomyomas.
    Zhang XL; Zheng RQ; Yang YB; Huang DM; Song Q; Mao YJ; Li YH; Zheng ZJ
    Chin Med J (Engl); 2010 Nov; 123(21):3095-9. PubMed ID: 21162962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
    Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
    J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Occult Uterine Sarcoma before Hysterectomy for Women with Leiomyoma or Abnormal Bleeding.
    Lentz SE; Zaritsky E; Tucker LY; Lee C; Lazo IM; Niihara A; Yamamoto M; Raine-Bennett T
    J Minim Invasive Gynecol; 2020; 27(4):930-937.e1. PubMed ID: 31352067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative Interventions to Minimize Blood Loss at the Time of Hysterectomy for Uterine Leiomyomas: A Systematic Review and Meta-analysis.
    Gingold JA; Chichura A; Harnegie MP; Kho RM
    J Minim Invasive Gynecol; 2019; 26(7):1234-1252.e1. PubMed ID: 31039407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
    J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas.
    Leibsohn S; d'Ablaing G; Mishell DR; Schlaerth JB
    Am J Obstet Gynecol; 1990 Apr; 162(4):968-74; discussion 974-6. PubMed ID: 2327466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Differentiation of Uterine Sarcoma from Leiomyoma: Comparison of Three Models Based on Different Segmentation Volumes Using Radiomics.
    Xie H; Zhang X; Ma S; Liu Y; Wang X
    Mol Imaging Biol; 2019 Dec; 21(6):1157-1164. PubMed ID: 30850967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.